Brendan Delaney's most recent trade in BeyondSpring Inc was a trade of 21,822 Stock Options (right to buy) done . Disclosure was reported to the exchange on April 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeyondSpring Inc | Brendan Delaney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2025 | 21,822 | 21,822 | - | - | Stock Options (right to buy) | |
| Whitehawk Therapeutics Inc. | Brendan Delaney | Director, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 235,000 | 235,000 | - | - | Stock option (right to buy) | |
| Whitehawk Therapeutics Inc. | Brendan Delaney | Director, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Whitehawk Therapeutics Inc. | Brendan Delaney | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 26 Sep 2022 | 20,000 | 20,000 | - | 12.5 | 250,000 | Common Stock |
| Whitehawk Therapeutics Inc. | Brendan Delaney | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 61,000 | 61,000 | - | - | Stock option (right to buy) | |
| Whitehawk Therapeutics Inc. | Brendan Delaney | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 260,000 | 260,000 | - | - | Stock option (right to buy) |